(Q46131292)

19 December 2017

title

Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment (English)

1 reference

19 December 2017

1 reference

1 reference

Tove Olafsen

1

1 reference

19 December 2017

Vania E Kenanova

series ordinal

2

1 reference

19 December 2017

Anna M Wu

series ordinal

3

1 reference

19 December 2017

publication date

1 January 2006

1 reference

19 December 2017

published in

Nature Protocols

1 reference

19 December 2017

volume

1

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

2048-2060

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/nprot.2006.322

exact match

0 references

cites work

Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences.

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

An engineered human IgG1 antibody with longer serum half-life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

pPIC9-Fc: a vector system for the production of single-chain Fv-Fc fusions in Pichia pastoris as detection reagents in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Monoclonal antibody therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Increasing the serum persistence of an IgG fragment by random mutagenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Engineered human IgG antibodies with longer serum half-lives in primates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Arming antibodies: prospects and challenges for immunoconjugates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Tailoring antibodies for radionuclide delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

The transmission of immunity from mother to young and the catabolism of immunoglobulins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Isolation and characterization of an Fc receptor from neonatal rat small intestine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Rapid and efficient site-specific mutagenesis without phenotypic selection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

A simple and efficient method for the oligonucleotide-directed mutagenesis using plasmid DNA template and phosphorothioate-modified nucleotide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

A simple and rapid method for the selection of oligodeoxynucleotide-directed mutants.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Conserved and nonconserved functions of the yeast and human TATA-binding proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Site-directed mutagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Approaches to DNA mutagenesis: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Hybridization of synthetic oligodeoxyribonucleotides to ΦX174 DNA: the effect of single base pair mismatch

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

1 Preparation of monoclonal antibodies: Strategies and procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

A program package for simulation and parameter estimation in pharmacokinetic systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

An efficient one-step site-directed and site-saturation mutagenesis protocol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Expression of single-chain Fv-Fc fusions in Pichia pastoris

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Immunoreactivity, stability, pharmacokinetics and biodistribution of a monoclonal antibody to human leukemic B cells after three different methods of radioiodination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.322

31 March 2020

Identifiers

DOI

10.1038/NPROT.2006.322

1 reference

19 December 2017

1 reference

19 December 2017